SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is attracting significant attention as traders debate whether the stock represents a deep-value buying opportunity or a declining asset amid concerns over U.S. consumer spending, menu pricing, and intense competition. While many investors view the recent pullback as a historic entry point for a defensive blue-chip stock, others argue that long-term structural issues and shifting consumer preferences suggest further downside.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Investors are largely divided on the asset, with many holding long-term conviction based on the network's decentralized cloud and AI infrastructure, while others remain frustrated by persistent price declines and token dilution concerns. The conversation is currently dominated by long-term holders debating the project's technological utility versus its historical market performance.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

The stock is attracting attention due to high short interest and market anticipation of a signed Power Purchase Agreement (PPA) and tenant deal for its Texas data center project. Traders are largely focused on a potential short squeeze, citing significant institutional accumulation and the belief that the company's off-grid energy strategy provides a unique advantage in the data center market.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv is trending as the community highlights its role in the AI data center buildout, specifically regarding power delivery and thermal management solutions. Traders are expressing bullish sentiment, focusing on the company's strong guidance, backlog growth, and expansion in global manufacturing capacity to meet rising demand from hyperscalers.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is experiencing a parabolic surge driven by strong buying momentum, a technical breakout above long-term resistance, and optimism surrounding the upcoming launch of its first spot ETF. While many traders are celebrating the price gains and comparing the asset to Bitcoin's early growth, others are warning of potential volatility and expressing skepticism regarding the sustainability of the move.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is trending as investors debate the asset's long-term potential, citing its low circulating supply and institutional pivot while some express frustration over persistent price stagnation compared to other DeFi tokens. Community members are divided, with some actively accumulating on dips while others criticize the lack of significant momentum and label the project's price action as stagnant.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing intense discussion regarding its commercial rollout and upcoming earnings, with traders debating the potential for a short squeeze against a backdrop of high institutional ownership and conflicting sentiment over institutional positioning. While some investors emphasize the long-term value of DefenCath and anticipation for Rezzayo, others are focused on volatility and potential downside risks leading into the reporting date.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending after being selected for inclusion in the S&P 500, a development that triggered significant bullish sentiment and after-hours price appreciation as traders anticipate mechanical buying pressure from index-tracking funds. The conversation is further fueled by community interest in the company's role in powering AI data centers and ongoing retail speculation surrounding recent political stock disclosures.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

The stock is receiving attention following a significant decline after the failure of its Phase 3 Aspire trial for an Angelman syndrome treatment, which missed both primary and secondary endpoints. While some investors view the sell-off as a severe overreaction and a buying opportunity due to the company's remaining commercial portfolio and upcoming catalysts, others express concern over the pipeline setback and the resulting shift in focus toward commercial execution and cost-cutting.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Elevated reported short interest, a perceived tight float, buybacks and call-heavy options positioning are driving a dominant short- and gamma-squeeze thesis around Groupon. Bullish traders view the AI-led turnaround and earnings outlook as potential catalysts, while skeptics argue the squeeze depends on fresh volume and question whether the underlying business and short-interest data justify the optimism.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Transmedics is trending primarily due to a significant sell-off following a first-quarter earnings report that saw an earnings per share miss despite revenue growth, with investors debating whether the company's margin compression is a temporary cost of aggressive global expansion or a longer-term fundamental issue. While some traders are aggressively accumulating shares at lower prices, citing the company's long-term organ transplant technology potential, others are exiting, concerned that management's high spending and recent performance warrant a valuation reset.

Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?

TransMedics' rapid revenue growth and cheaper valuation face rising margin pressure as heavy investment raises execution risks.

Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?

TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX PR Newswire NEW YORK, Aug...

TransMedics to Present at Upcoming September Investor Conferences

TransMedics to Present at Upcoming September Investor Conferences TransMedics to Present at Upcoming September Investor Conferences PR Newswire ANDOVER, Mass., Aug. 31, 2026 ANDOVER, Mass., Aug. 31, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology...

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Aug. 25, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost...

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Aug. 17, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost...

TransMedics Stock Dips Post Q2 Earnings Miss, Margins Contract

TMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.

TransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for TransMedics (TMDX) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

Transmedics Group Inc

TMDX Stock Rallies As Analyst Sees 77% Upside  — Here’s Why  

Equity

Bearish Sentiment

Buying - this is temporary noise

Holding existing position

Selling / Trimming / Shorting

Watching from the sidelines

$TMDX is sliding after Stifel flagged a surge in "dry runs.". TransMedics investors are divided: is this a temporary operational blip or a structural crack in the growth story? Cast your vote below.

$TMDX sliding on &quot;dry run&quot; concerns - are you buying this dip?

Stocktwits

 sliding on "dry run" concerns - are you buying this dip?

Current Price	$89.98
Prev Close	$86.98
Open	$84.63
Dividend Yield	0.00%
50-Day Moving Average	$80.14
Beta	1.27
Avg. Volume	910,793.11
PE Ratio	23.41

52-Week High	$156.00
52-Week Low	$60.11
Market Capitalization	$3.02B
EPS (Annual)	$4.87
Price to Book	6.01
Revenue Per Employee	$674,269.49

Feed

News

Sentiment

Earnings

Fundamentals

Info

TMDX Fundamentals